Not Yet Recruiting
Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination
NCT07133802
- Conditions
- Prevention of Influenza
- Locations
-
Not specified